Latest:
Key Investigational Approaches for Acute and Chronic GVHD
Drs Yi-Bin Chen and Sophie Paczesny highlight data from key investigational approaches presented at recent meetings.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Marina Frimer, MD, FACOG, FACS
Latest:
Dr. Frimer on the Exploration of Maintenance with Niraparib in Uterine Serous Carcinoma
Marina Frimer, MD, FACOG, FACS, discusses the exploration of maintenance with niraparib in a phase 2 trial in patients with advanced or platinum-sensitive recurrent uterine serious carcinoma
Horacio J. Asbun, MD
Latest:
Mapping Progress in Pancreatic Cancer Surgery: Leveraging New Technology
In this last episode of OncChats: Mapping Progress Made in Pancreatic Cancer Surgery, Horacio J. Asbun, MD, and Domenech Asbun, MD, explain how augmented reality or artificial intelligence may be utilized to improve outcomes for patients with pancreatic cancer who are undergoing surgical procedures.
Jacqueline Aredo, MD, MS
Latest:
Dr Aredo on the Molecular Distribution of Screening-Eligible Patients With NSCLC
Jacqueline Aredo, MD, MS, discusses findings from a study assessing the molecular distribution of driver mutations and tumor suppressor gene mutations in patients with non–small cell lung cancer who are eligible for lung cancer screening.
Shahzad Raza, MD
Latest:
Prevalence of Eye Toxicities in Patients With Cancer Is Much Higher Than Previously Known
In the real-world setting, cases of ocular adverse effects have emerged with greater frequency both in new and established therapies than has been previously observed in many clinical trials.